This paper is only available as a PDF. To read, Please Download here.
Abstract
The relationship between the uterus and the IUD was studied selectively with hysterosalpingograms
in 18 menorrhagic women previously treated with Meclofenamic acid (M Ac.), a well
known anti-inflammatory drug. Major anomalies (embedding, perforation, rotation) were
found in 28.6% of those patients who responded positively to M Ac. In contrast, major
anomalies were found in 63.6% of those patients who responded negatively to the drug.
It is proposed that the negative response to M Ac. might be due to severe macroscopic
disturbances of the uterine wall-IUD relationship. The degree of response to M Ac.
might contribute to the decision to remove the IUD from menorrhagic women.
In addition, 84.7% anomalies (deformities, embedding, perforation) in the uterine-IUD
relationship were found in 13 women with a T-shape IUD device. The fact that those
anomalies are related to the tip of the horizontal arm justifies future studies using
shortened arms to diminish hypermenorrhea induced by T-shape devices or attempts to
use IUDs which do not have the conventional plastic frame, as in the Cu-Fix IUD which
has been mentioned as particularly useful to prevent bleeding side effects and pain
induced by conventional IUDs. The Cu-Fix IUD consists of 6 sleeves made of pure (99.99%)
copper, each sleeve with a length of 5 mm and an outer diameter of approximately 2.2
mm, threaded on surgical 00 monofilament polypropylene (ProleneR, Ethicon). The total area of exposed copper is approximately 390 mm2. The sleeves are prevented from sliding off the suture by 2 smaller copper tubules
crushed on the thread in both ends of the IUD structure. This thread-type, copper-bearing
device has been designed to overcome the most common IUD-related problems, bleeding
and pain.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Fecundidad Y salud materno infantil.Boletín Asociación Chilena de Protección de la Familia. 1986; 7: 26-46
- Menstrual blood loss with intrauterine devices.Lancet. 1976; i: 387-390
- Reduction by mefenamic acid of increased menstrual blood loss with intrauterine contraception.Br J Obstet Gynaecol. 1978; 85: 53-62
- Treatment of increased menstrual blood loss in IUD users.Contraception. 1987; 36: 145-157
- Dimensional and architectural disproportion between the intrauterine device and the uterine cavity. A cause of bleeding.Fertil Steril. 1971; 22: 514-521
- uterine geometry and IUD performance.in: Hafez ESE Van Os WAA Medicated intrauterine devices, physiological and clinical aspects. Martinus Nijhoff, 1980: 11-12
- Avoidance of the dimensional incompatibility as the main reason for side effects in intrauterine contraception.Contracep Del Sys. 1981; 2: 21-26
- Morphologic studies on IUD-induced metrorrhagia. II. Surface changes of the endometrium and microscopic localization of bleeding sites.Contraception. 1979; 19: 63-80
- Evaluation of intrauterine devices. Ninth Progress Report of the Cooperative Statistical Program.Stud Fam Plann. 1970; 55: 1-40
- Who Special Programme of Research, Development and Research Training in Human Reproduction, 13th Report. 1984; (Geneva)
- Quantitative menstrual blood loss in IUD users.Contraception. 1987; 36: 129-144
- Consequences of uterine blood loss caused by various intrauterine contraceptive devices in South American women.Contraception. 1988; 38: 1-18
- Effect of Meclofenamic acid on menstrual blood loss of menorrhagic IUD wearers.Rev Chil Obstet Gynaecol. 1988; 1: 43-56
- The role of prostaglandins and allied substances in uterine haemostasis.Contraception. 1987; 36: 23-35
- Fibrinolytic activity and intrauterine contraceptive devices.in: Zatuchni GI Goldsmith A Sciarra JJ Intrauterine contraception. Harper and Row, Philadelphia1985: 307-318
- Determination of menstrual blood loss.Scan J Clin Lab Invest. 1964; 16: 244-248
- On quantifying menstrual blood loss.Contraception. 1977; 16: 283-285
- A rapid method for measuring menstrual blood loss using automatic extraction.Contraception. 1977; 16: 269-282
- Cavimeter uterine measurements and IUD clinical correlation.in: Zatuchni GI Goldsmith A Sciarra JJ Intrauterine contraception. Harper and Row, Philadelphia1985: 142-162
- The Copper-Fix (Cu-Fix): a new concept in IUD technology.Adv Contracept. 1988; 4: 1-9
Article info
Publication history
Accepted:
June 20,
1989
Received:
January 31,
1989
Identification
Copyright
© 1989 Published by Elsevier Inc.
